1 |
Wu P, Zhao J, Shen X, Liang X, He C, Yin L, Xu F, Li H, Tang H. Research progress on the structure and biological diversities of 2-phenylindole derivatives in recent 20 years. Bioorg Chem 2023;132:106342. [PMID: 36621157 DOI: 10.1016/j.bioorg.2023.106342] [Reference Citation Analysis]
|
2 |
Pimenov N, Kostyushev D, Komarova S, Fomicheva A, Urtikov A, Belaia O, Umbetova K, Darvina O, Tsapkova N, Chulanov V. Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia. Pathogens 2022;11. [PMID: 36558817 DOI: 10.3390/pathogens11121482] [Reference Citation Analysis]
|
3 |
Matsumori A. Novel Biomarkers of Inflammation for the Management of Diabetes: Immunoglobulin-Free Light Chains. Biomedicines 2022;10:666. [DOI: 10.3390/biomedicines10030666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Akira Matsumori. Targeting Inflammation in the Diagnosis, Management, and Prevention of Cardiovascular Diseases. Glob Heart 2022;17:80. [PMID: 36382160 DOI: 10.5334/gh.1156] [Reference Citation Analysis]
|
5 |
Schultheiss HP, Baumeier C, Aleshcheva G, Bock CT, Escher F. Viral Myocarditis-From Pathophysiology to Treatment. J Clin Med 2021;10:5240. [PMID: 34830522 DOI: 10.3390/jcm10225240] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|
6 |
Schultheiss HP, Baumeier C, Pietsch H, Bock CT, Poller W, Escher F. Cardiovascular consequences of viral infections: from COVID to other viral diseases. Cardiovasc Res 2021:cvab315. [PMID: 34609508 DOI: 10.1093/cvr/cvab315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|